Clinical trial
New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy…
NCT00044577 · ViiV Healthcare, Industry · Completed
Key facts
| NCT number | NCT00044577 |
|---|---|
| Title | New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects |
| Official title | See Detailed Description |
| Lead sponsor | ViiV Healthcare, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infection, Human Immunodeficiency Virus I, HIV Infection |
| Intervention type | Drug |
| Interventions | abacavir/lamivudine, abacavir, lamivudine, tenofovir |
| Enrollment | 166 |
| Start date | Jul 16, 2002 |
| Primary completion | May 25, 2004 |
| Completion | May 25, 2004 |
| First posted | Sep 4, 2002 |
| Last update posted | Mar 24, 2020 |
| Countries | Belgium, Canada, France, Germany, Italy, Portugal, Spain, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: